Anti-Inflammatory Properties of Curcumin as Add-On Therapy in Patients with MS—Prospective, Comparative, Randomized, Pilot Study

<b>Background</b>: Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system and is the leading cause of neurological disability. Currently, the main strategy for MS therapy is the use of disease-modifying therapies (DMTs). If low-efficacy DMTs are ineffective, patients a...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Anna Kukushkina, Vladimir Rogovskii, Olga Zhilenkova, Timur Sadekov, Mikhail Melnikov, Alexey Boyko
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2026-04-01
coleção:	Pharmaceutics
Assuntos:	multiple sclerosis neuroinflammation curcumin add-on therapy gut microbiota microbiota markers
Acesso em linha:	https://www.mdpi.com/1999-4923/18/5/519
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!